Tezepelumab Reduces Exacerbation Rates in Patients with Severe Asthma, Trial Results Show
Asthma, News
Patients with severe and uncontrolled asthma who took tezepelumab had significantly lower annual asthma exacerbation rates than those on placebo, according to the latest results of the PATHWAY Phase 2b trial. ... Read more